Key regulatory roles of PRDM1 in human NK-cell differentiation and activation
PRDM1, encoding a transcription factor (TF), regulates plasma cell and CD8<sup>+</sup> T-cell terminal differentiation and T<sub>h</sub>2 lineage specification, while its role in human NK-cell differentiation and homeostasis is largely unknown. Here, we employed a multi-omics approach to dissect the transcriptional control of PRDM1 on human NK-cells. PRDM1 is important in NK-cell terminal differentiation based on gene expression profiling and its targeting of key regulators in the process. PRDM1-deleted NK-cells displayed a less mature phenotype simulating the CD56<sup>bright</sup> NK-cell population accompanied by upregulation of stem-like gene signatures. PRDM1-bound genes were enriched in T/NK-cell receptor signaling, activation, and NK-cell effector functions. PRDM1 could function as a transcriptional repressor as well as an activator as its activities may be modified by association with different TFs and co-factors. The kinetics of its action also varies among its target genes. As a homeostatic factor, PRDM1 is induced upon IL-2 and feeder cell stimulation, but its ability to restrict NK-cell growth upon feeder stimulation may be counteracted by the AP-1-induced transcriptional network. The loss of PRDM1 activity is frequent in NK-cell malignancies which may lead to decreased homeostatic control, impaired terminal differentiation, enhanced cellular fitness, and the acquisition of more stem-like features, thereby promoting lymphomagenesis.
Authors
- Can Küçük (ORCID: https://orcid.org/0000-0001-5540-9012)
- Sheng Pan
- Wing C. Chan (ORCID: https://orcid.org/0000-0002-6243-6008)
- Ru Chen
- Timothy W. McKeithan (ORCID: https://orcid.org/0000-0003-2242-3074)
- Xuxiang Liu (ORCID: https://orcid.org/0000-0002-1677-0814)
- Roger E. Moore (ORCID: https://orcid.org/0000-0002-8907-2144)
- Javeed Iqbal (ORCID: https://orcid.org/0000-0003-3668-0629)
- Krystie Chew (ORCID: https://orcid.org/0000-0002-7860-8353)
- Esra Esmeray Sönmez (ORCID: https://orcid.org/0000-0003-3159-2005)
- Logan Lee (ORCID: https://orcid.org/0000-0001-5496-281X)
- Krystine Garcia‐Mansfield (ORCID: https://orcid.org/0000-0002-9089-2254)
- Qiang Gong (ORCID: https://orcid.org/0000-0001-8502-6813)
- Katarzyna Dąbrowska (ORCID: https://orcid.org/0000-0001-7833-0374)
- Patrick Pirrotte (ORCID: https://orcid.org/0000-0003-1360-6039)
- Yuping Li (ORCID: https://orcid.org/0000-0002-6514-6719)
- Jinhui Wang (ORCID: https://orcid.org/0000-0002-3499-4336)
- Haiqing Li (ORCID: https://orcid.org/0000-0001-5583-2240)
- Jibin Zhang (ORCID: https://orcid.org/0000-0003-3099-6665)
- Kunal Shetty (ORCID: https://orcid.org/0000-0003-1065-2734)
- Yunfei Shi
- Gehong Dong
Institutions
- Translational Genomics Research Institute (US)
- Beijing Tongren Hospital (CN)
- City Of Hope National Medical Center (US)
- Izmir University (TR)
- Baylor College of Medicine (US)
- Capital Medical University (CN)
- Dokuz Eylül University (TR)
- Peking University (CN)
- Beijing Tian Tan Hospital (CN)
- Peking University Cancer Hospital (CN)
- City of Hope (US)
- University of Nebraska Medical Center (US)
- The University of Texas Health Science Center at Houston (US)
Publication Details
- Journal
- Leukemia
- Published
- 2025-12-09
- DOI
- https://doi.org/10.1038/s41375-025-02815-z
- Primary Topic
- Immune Cell Function and Interaction
- Type
- article
- Field-Weighted Citation Impact
- 0.00